XML 34 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Stock-Based Compensation Plans
9 Months Ended
Sep. 30, 2020
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation Plans
NOTE 14 – STOCK-BASED COMPENSATION PLANS
The Company grants stock options and stock equivalent units (“SEUs”) from time to time as a long-term performance incentive. In certain cases the grants are subject to performance conditions such as the Company’s stock price. Where performance conditions apply the Monte Carlo simulation model is used to determine the fair values. Otherwise the Black-Scholes model is used to determine the fair values.
Stock option plans
The following table summarizes the transactions of the Company’s stock option plans for the nine months ended September 30, 2020:
 
    
Number of
Options
    
Weighted
Average
Exercise
Price
    
Weighted
Average
Grant-Date

Fair Value
 
Outstanding at December 31, 2019
     504,459      $ 33.05      $ 41.35  
Granted - at discount
     63,950      $ 1.11      $ 76.80  
- at market value
     10,419      $ 95.70      $ 18.69  
Exercised
     (92,551    $ 12.84      $ 48.71  
Forfeited
     (19,837    $ 34.07      $ 40.65  
  
 
 
       
Outstanding at September 30, 2020
     466,440      $ 34.04      $ 44.27  
  
 
 
       
At September 30, 2020, there were 35,157 stock options that were exercisable, of which 7,611 had performance conditions attached.
The stock option compensation cost for the first nine months of 2020 was $4.4 million (first nine months of 2019 – $4.9 million). The total intrinsic value of options exercised in the first nine months of 2020 was $4.7 million (first nine months of 2019 – $2.7 million).
The total compensation cost related to
non-vested
stock options not yet recognized at September 30, 2020 was $8.4 million and this cost is expected to be recognized over the weighted-average period of 1.75 years.
Stock equivalent units
The following table summarizes the transactions of the Company’s SEUs for the nine months ended September 30, 2020:
 
    
Number of
SEUs
    
Weighted
Average
Exercise
Price
    
Weighted
Average
Grant-Date

Fair Value
 
Outstanding at December 31, 2019
     390,816      $ 3.69      $ 59.91  
Granted - at discount
     113,107      $ 0.00      $ 76.63  
- at market value
     3,634      $ 95.70      $ 18.69  
Exercised
     (93,057    $ 0.82      $ 60.04  
Forfeited
     (21,336    $ 0.68      $ 65.62  
  
 
 
       
Outstanding at September 30, 2020
     393,164      $ 4.32      $ 64.00  
  
 
 
       
At September 30, 2020 there were 53,146 SEUs that are exercisable, of which 46,614 had performance conditions attached.
The charges for SEUs are spread over the life of the award subject to a revaluation to fair value each quarter. The revaluation may result in a charge or a credit to the income statement in the quarter dependent upon our share price and other performance criteria.
The SEU compensation for the first nine months of 2020 was a $4.9 million credit (first nine months of 2019 – $14.0 million charge). The total intrinsic value of SEUs exercised in the first nine months of 2020 was $6.3 million (first nine months of 2019 – $6.8 million).
The weighted-average remaining vesting period of
non-vested
SEUs is 2.05 years.